|
Programme
Saturday, September
6, 2003 -
Thursday, September 4, 2003
- Friday,
September 5, 2003
9.00 – 11.00
Room K1/K2 |
Diagnosis and treatment |
| |
|
|
Chairpersons: |
Lars Agreus, Sweden
Peter Malfertheiner, Germany |
| |
|
| |
Focus/Round Tables |
| |
Introduction
Lars Agreus, SwedenThe true
history and the future
Barry Marshall, Australia
Diagnosis - Strategies for testing
P. Bytzer, Denmark
Resistance – current status and
consequences
L. Engstrand, Sweden
“Test and treat”
W.A. de Boer, The Netherlands
“Test and scope”
N. Vakil, United States
“Empiric treatment or scope them all -
the extremes”
B. Delaney, United Kingdom
Discussion
NSAID management
R. Jones, United Kingdom |
| |
|
| |
State of the Art Lecture
N. Talley, Australia |
| |
|
|
10.30 – 11.00 |
Coffee Break |
| |
|
11.00 – 13.00
Room K1/K2 |
Highlights in
H.pylori – Workshop Reports |
| |
|
Chairpersons:
|
Mario Quina, Portugal
Lars Lundell, Sweden |
| |
|
| |
Pediatric Issues and
Diagnosis
H. Rautelin, FinlandInfl
ammation vs host response
R. Ferrero, France
Microbiology, Probiotics and Genomics
A. Labigne, France
Rescue and novel treatments
F. Bazzoli, Italy
Clinical and Epidemiological issues
D. Forman, United Kingdom
Extragastric benign and malignant
Diseases
A. Gasbarrini, Italy
Microbial Pathogenesis
S. Backert, Germany
Preneoplastic and neoplastic diseases
T Rokkas, Greece
Report from the Probiotics Pre-Meeting
J. Versalovic, United States, E. Norin, Sweden |
| |
|
13.00 – 13.15
Room K1/K2 |
Presentation of EHSG
2004 – Closing of the Workshop |
| |
|
|
|